‘The first time ever in my career’: Senior Citi executive on why the ultrawealthy want to diversify away from America11 July 2026
A New Study Targets Genetic Risk For Mental IllnessBy Press Room19 June 2025 For centuries, the genetic lottery has shaped our health and our futures. In Destiny’s Child No Longer: Rewriting Genetic Fate,…
Generative AI Goes Head-To-Head With Mental Health TherapistsBy Press Room7 April 2025 In today’s column, I am continuing my ongoing series about the impact of generative AI in the health and medical…
Promising Schizophrenia Drug, Cobenfy, Will Likely Face Access ChallengesBy Press Room5 November 2024 Cobenfy (xanomeline/trospium chloride; formerly KarXT) was approved for schizophrenia in adults by the Food and Drug Administration in late September.…